For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) closed at $998.23 down -0.97% from its previous closing price of $1007.96. In other words, the price has decreased by -$0.97 from its previous closing price. On the day, 0.73 million shares were traded. REGN stock price reached its highest trading level at $1013.0875 during the session, while it also had its lowest trading level at $997.82.
Ratios:
For a deeper understanding of Regeneron Pharmaceuticals, Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 33.05. For the most recent quarter (mrq), Quick Ratio is recorded 4.62 and its Current Ratio is at 5.44. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on September 24, 2024, Downgraded its rating to Market Perform and sets its target price to $1077 from $1175 previously.
On March 12, 2024, Bernstein started tracking the stock assigning a Outperform rating and target price of $1125.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on January 12, 2024, whereas the target price for the stock was revised from $884 to $1076.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 01 ’24 when RYAN ARTHUR F sold 100 shares for $1048.78 per share. The transaction valued at 104,878 led to the insider holds 17,582 shares of the business.
McCourt Marion sold 1,000 shares of REGN for $1,054,060 on Oct 01 ’24. The EVP Commercial now owns 12,931 shares after completing the transaction at $1054.06 per share. On Oct 01 ’24, another insider, MARION E MCCOURT, who serves as the Officer of the company, bought 1,000 shares for $1054.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REGN now has a Market Capitalization of 110039883776 and an Enterprise Value of 100638081024. As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.44, and their Forward P/E ratio for the next fiscal year is 20.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.16 while its Price-to-Book (P/B) ratio in mrq is 3.90. Its current Enterprise Value per Revenue stands at 7.461 whereas that against EBITDA is 22.269.
Stock Price History:
Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $769.19. The 50-Day Moving Average of the stock is -10.15%, while the 200-Day Moving Average is calculated to be -1.45%.
Shares Statistics:
For the past three months, REGN has traded an average of 538.73K shares per day and 609860 over the past ten days. A total of 107.60M shares are outstanding, with a floating share count of 106.30M. Insiders hold about 3.55% of the company’s shares, while institutions hold 86.56% stake in the company. Shares short for REGN as of 1727654400 were 1731813 with a Short Ratio of 3.21, compared to 1724976000 on 2099594. Therefore, it implies a Short% of Shares Outstanding of 1731813 and a Short% of Float of 1.66.
